| Name: | Dexamethasone EP Impurity K |
| Catalogue No. | VL273007 |
| CAS No. | 1809224-82-5 |
| Molecular Formula | C22H26O4 |
| Molecular Weight | 354.45 |
| Status | In-stock |
| IUPAC Name | 17,21-Dihydroxy-16α-methylpregna-1,4,7,9(11)-tetraene3,20-dione |
| Synonyms | Δ7,9 (11)-Dexamethasone |
| Description | Dexamethasone EP Impurity K (CAS No.: 1809224-82-5) or Δ7,9 (11)-Dexamethasone is an isoform of Dexamethasone. Dexamethasone drug delivery system (DDS) was later developed as a biodegradable intravitreal implant to give a sustained delivery of 700 μg of dexamethasone to the retina and vitreous and is sanctioned by the FDA. |
| References | London, Nikolas J. S., et al. “The Dexamethasone Drug Delivery System: Indications and Evidence.” Advances in Therapy, vol. 28, no. 5, Mar. 2011, pp. 351–66,https://doi.org/10.1007/s12325-011-0019-z. |
![(16α)-21-[(Ethoxycarbonyl)oxy]-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione](/public/site/files/site_images/thumb_16alpha-21-ethoxycarbonyl-oxy-17-hydroxy-16-methylpregna-1-4-9-11-triene-3-20-dione47031.png)
